Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine
Current Oncology · 22.02.2023 · 30 (3) · 2673-2701
DOI: 10.3390/curroncol30030203 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 22.02.2023. Verfasst von Maurizio Cè und 9 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, Via Festa del Perdono 7, 20122 Milan, Italy. Hauptthemen laut MEDLINE: Artificial Intelligence, Brain Neoplasms. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The application of artificial intelligence (AI) is accelerating the paradigm shift towards patient-tailored brain tumor management, achieving optimal onco-functional balance for each individual. AI-based models can positively impact different stages of the diagnostic and therapeutic process. Although the histological investigation will remain difficult to replace, in the near future the radiomic approach will allow a complementary, repeatable and non-invasive characterization of the lesion, assisting oncologists and neurosurgeons in selecting the best therapeutic option and the correct molecular target in chemotherapy. AI-driven tools are already playing an important role in surgical planning, delimiting the extent of the lesion (segmentation) and its relationships with the brain structures, thus allowing precision brain surgery as radical as reasonably acceptable to preserve the quality of life. Finally, AI-assisted models allow the prediction of complications, recurrences and therapeutic response, suggesting the most appropriate follow-up. Looking to the future, AI-powered models promise to integrate biochemical and clinical data to stratify risk and direct patients to personalized screening protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Postgraduation School in Radiodiagnostics, Università degli Studi di Milano, Via Festa del Perdono 7, 20122 Milan, Italy.
- Postgraduation School in Radiodiagnostics, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
- Radiology Department, San Raffaele Hospital, Via Olgettina 60, 20132 Milan, Italy.
- Radiology Department, Fatebenefratelli Hospital, ASST Fatebenefratelli Sacco, Piazza Principessa Clotilde 3, 20121 Milan, Italy.
ORCID-Profile: Maurizio Cè, Giovanni Irmici, Lydia Viviana Falsitta, Carlo Martinenghi, Michaela Cellina
Zitieren
APA
Cè, M., Irmici, G., Foschini, C., Danesini, G. M., Falsitta, L. V., Serio, M. L., Fontana, A., Martinenghi, C., Oliva, G., & Cellina, M. (2023). Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine. Current Oncology, 30(3), 2673-2701. https://doi.org/10.3390/curroncol30030203
Vancouver
Cè M, Irmici G, Foschini C, Danesini GM, Falsitta LV, Serio ML, et al. Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine. Current Oncology. 2023;30(3):2673-2701. doi:10.3390/curroncol30030203
BibTeX
@article{C2023,
author = {Cè, Maurizio and Irmici, Giovanni and Foschini, Chiara and Danesini, Giulia Maria and Falsitta, Lydia Viviana and Serio, Maria Lina and Fontana, Andrea and Martinenghi, Carlo and Oliva, Giancarlo and Cellina, Michaela},
title = {Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {3},
pages = {2673--2701},
doi = {10.3390/curroncol30030203}
}
EUVIMED